KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Clorox (CLX) EBT (2016 - 2026)

Clorox has reported EBT over the past 18 years, most recently at $256.0 million for Q1 2026.

  • For Q1 2026, EBT rose 0.79% year-over-year to $256.0 million; the TTM value through Mar 2026 reached $988.0 million, up 4.77%, while the annual FY2025 figure was $1.1 billion, 170.85% up from the prior year.
  • EBT for Q1 2026 was $256.0 million at Clorox, up from $215.0 million in the prior quarter.
  • Over five years, EBT peaked at $410.0 million in Q2 2025 and troughed at -$245.0 million in Q1 2023.
  • A 5-year average of $154.2 million and a median of $177.0 million in 2024 define the central range for EBT.
  • Biggest five-year swings in EBT: plummeted 222.5% in 2023 and later skyrocketed 704.76% in 2025.
  • Year by year, EBT stood at $130.0 million in 2022, then grew by 4.62% to $136.0 million in 2023, then surged by 74.26% to $237.0 million in 2024, then decreased by 9.28% to $215.0 million in 2025, then increased by 19.07% to $256.0 million in 2026.
  • Business Quant data shows EBT for CLX at $256.0 million in Q1 2026, $215.0 million in Q4 2025, and $107.0 million in Q3 2025.